Light Mode
$0.5585 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.5585, $0.0315 below the day’s high of $0.5900
-0.04 (-6.76%) / 6M
Momentum, market sentiment, and recent alerts
KAPA reads poor: price sits below both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is -51.4%.
No alerts for KAPA in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.